DBT approves funding for three companies for developing coronavirus vaccine

The DBT said a multifaceted approach is being adopted to ensure that vaccine companies utilising different platforms and at different stages of development are fast tracked through a research consortium under funding from the National Biopharma Mission, an initiative launched in 2017 to support development of vaccines and drugs.​

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34MS8ci
via IFTTT